ANI Pharmaceuticals
ANIP
ANIP
120 hedge funds and large institutions have $293M invested in ANI Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 126 → 120 (-6)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
67% less call options, than puts
Call options by funds: $614K | Put options by funds: $1.86M
Holders
120
Holding in Top 10
1
Calls
$614K
Puts
$1.86M
Top Buyers
| 1 | +$7.25M | |
| 2 | +$4.81M | |
| 3 | +$3.71M | |
| 4 |
Goldman Sachs
New York
|
+$3.57M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3.02M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$2.49M | |
| 3 | -$1.36M | |
| 4 |
Two Sigma Investments
New York
|
-$1.26M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.08M |